BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

506 related articles for article (PubMed ID: 30142541)

  • 1. Midkine downregulation increases the efficacy of quercetin on prostate cancer stem cell survival and migration through PI3K/AKT and MAPK/ERK pathway.
    Erdogan S; Turkekul K; Dibirdik I; Doganlar O; Doganlar ZB; Bilir A; Oktem G
    Biomed Pharmacother; 2018 Nov; 107():793-805. PubMed ID: 30142541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Midkine silencing enhances the anti-prostate cancer stem cell activity of the flavone apigenin: cooperation on signaling pathways regulated by ERK, p38, PTEN, PARP, and NF-κB.
    Erdogan S; Turkekul K; Dibirdik I; Doganlar ZB; Doganlar O; Bilir A
    Invest New Drugs; 2020 Apr; 38(2):246-263. PubMed ID: 30993586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The flavonoid apigenin reduces prostate cancer CD44(+) stem cell survival and migration through PI3K/Akt/NF-κB signaling.
    Erdogan S; Doganlar O; Doganlar ZB; Serttas R; Turkekul K; Dibirdik I; Bilir A
    Life Sci; 2016 Oct; 162():77-86. PubMed ID: 27569589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zoledronic acid inhibits the growth of cancer stem cell derived from cervical cancer cell by attenuating their stemness phenotype and inducing apoptosis and cell cycle arrest through the Erk1/2 and Akt pathways.
    Wang L; Liu Y; Zhou Y; Wang J; Tu L; Sun Z; Wang X; Luo F
    J Exp Clin Cancer Res; 2019 Feb; 38(1):93. PubMed ID: 30791957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quercetin‑3‑methyl ether suppresses human breast cancer stem cell formation by inhibiting the Notch1 and PI3K/Akt signaling pathways.
    Cao L; Yang Y; Ye Z; Lin B; Zeng J; Li C; Liang T; Zhou K; Li J
    Int J Mol Med; 2018 Sep; 42(3):1625-1636. PubMed ID: 29956731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of Midkine Suppresses Prostate Cancer CD133
    Erdogan S; Doganlar ZB; Doganlar O; Turkekul K; Serttas R
    Am J Med Sci; 2017 Sep; 354(3):299-309. PubMed ID: 28918838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The natural flavonoid apigenin sensitizes human CD44
    Erdogan S; Turkekul K; Serttas R; Erdogan Z
    Biomed Pharmacother; 2017 Apr; 88():210-217. PubMed ID: 28107698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poziotinib suppresses ovarian cancer stem cell growth via inhibition of HER4-mediated STAT5 pathway.
    Lee H; Kim JW; Choi DK; Yu JH; Kim JH; Lee DS; Min SH
    Biochem Biophys Res Commun; 2020 May; 526(1):158-164. PubMed ID: 32201081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quercetin inhibits the growth of human gastric cancer stem cells by inducing mitochondrial-dependent apoptosis through the inhibition of PI3K/Akt signaling.
    Shen X; Si Y; Wang Z; Wang J; Guo Y; Zhang X
    Int J Mol Med; 2016 Aug; 38(2):619-26. PubMed ID: 27278820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naringenin-Induced Apoptotic Cell Death in Prostate Cancer Cells Is Mediated via the PI3K/AKT and MAPK Signaling Pathways.
    Lim W; Park S; Bazer FW; Song G
    J Cell Biochem; 2017 May; 118(5):1118-1131. PubMed ID: 27606834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytoprotective effect of neuropeptides on cancer stem cells: vasoactive intestinal peptide-induced antiapoptotic signaling.
    Sastry KS; Chouchane AI; Wang E; Kulik G; Marincola FM; Chouchane L
    Cell Death Dis; 2017 Jun; 8(6):e2844. PubMed ID: 28569785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acquisition of epithelial-mesenchymal transition and cancer stem cell phenotypes is associated with activation of the PI3K/Akt/mTOR pathway in prostate cancer radioresistance.
    Chang L; Graham PH; Hao J; Ni J; Bucci J; Cozzi PJ; Kearsley JH; Li Y
    Cell Death Dis; 2013 Oct; 4(10):e875. PubMed ID: 24157869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wogonin induces apoptosis and down-regulates survivin in human breast cancer MCF-7 cells by modulating PI3K-AKT pathway.
    Huang KF; Zhang GD; Huang YQ; Diao Y
    Int Immunopharmacol; 2012 Feb; 12(2):334-41. PubMed ID: 22182776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quercetin suppresses breast cancer stem cells (CD44
    Li X; Zhou N; Wang J; Liu Z; Wang X; Zhang Q; Liu Q; Gao L; Wang R
    Life Sci; 2018 Mar; 196():56-62. PubMed ID: 29355544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sinodielide A exerts thermosensitizing effects and induces apoptosis and G2/M cell cycle arrest in DU145 human prostate cancer cells via the Ras/Raf/MAPK and PI3K/Akt signaling pathways.
    Hatashita M; Taniguchi M; Baba K; Koshiba K; Sato T; Jujo Y; Suzuki R; Hayashi S
    Int J Mol Med; 2014 Feb; 33(2):406-14. PubMed ID: 24285252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quercetin inhibits migration and invasion of SAS human oral cancer cells through inhibition of NF-κB and matrix metalloproteinase-2/-9 signaling pathways.
    Lai WW; Hsu SC; Chueh FS; Chen YY; Yang JS; Lin JP; Lien JC; Tsai CH; Chung JG
    Anticancer Res; 2013 May; 33(5):1941-50. PubMed ID: 23645742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down-regulation of cyclin-dependent kinase-4 and MAPK through estrogen receptor mediated cell cycle arrest in human breast cancer induced by gold nanoparticle tagged toxin protein NKCT1.
    Bhowmik T; Gomes A
    Chem Biol Interact; 2017 Apr; 268():119-128. PubMed ID: 28322778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin combined with quercetin synergistically repressed prostate cancer cells via inhibition of VEGF/PI3K/Akt signaling pathway.
    Sun S; Gong F; Liu P; Miao Q
    Gene; 2018 Jul; 664():50-57. PubMed ID: 29678660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone marrow-derived mesenchymal stem cells increase drug resistance in CD133-expressing gastric cancer cells by regulating the PI3K/AKT pathway.
    Ji N; Yu JW; Ni XC; Wu JG; Wang SL; Jiang BJ
    Tumour Biol; 2016 Nov; 37(11):14637-14651. PubMed ID: 27619680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shikonin inhibits prostate cancer cells metastasis by reducing matrix metalloproteinase-2/-9 expression via AKT/mTOR and ROS/ERK1/2 pathways.
    Chen Y; Zheng L; Liu J; Zhou Z; Cao X; Lv X; Chen F
    Int Immunopharmacol; 2014 Aug; 21(2):447-55. PubMed ID: 24905636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.